Hee Jeong Kim

ORCID: 0000-0002-1343-8138
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Risks and Factors
  • MRI in cancer diagnosis
  • Estrogen and related hormone effects
  • Advanced Radiotherapy Techniques
  • Reproductive Biology and Fertility
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Radiopharmaceutical Chemistry and Applications
  • Advanced MRI Techniques and Applications
  • Brain Metastases and Treatment
  • Radiation Dose and Imaging
  • Advanced X-ray and CT Imaging
  • Cancer Cells and Metastasis
  • Advanced Breast Cancer Therapies
  • Coronary Interventions and Diagnostics
  • Metastasis and carcinoma case studies

University of Ulsan
1999-2025

Asan Medical Center
2009-2025

Ulsan College
1999-2025

Seoul Medical Center
2024

Seoul Veterans Hospital
2024

University of Yamanashi
2023

University of British Columbia
2023

National Cancer Center
2015-2017

Samsung Medical Center
2011-2017

Korea Institute of Radiological and Medical Sciences
2015

To determine the updated long-term outcomes of Addition Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain Premenopausal or Regain Vaginal Bleeding After Chemotherapy (ASTRRA) trial.This study is a post-trial follow-up ASTRRA trial, involving 1,483 premenopausal women younger than 45 years treated with definitive surgery after completing adjuvant neoadjuvant chemotherapy for estrogen receptor-positive breast cancer. Patients were randomly assigned...

10.1200/jco.23.00557 article EN Journal of Clinical Oncology 2023-08-22
Matteo Lambertini Eva Blondeaux Elisa Agostinetto Anne-Sophie Hamy Hee Jeong Kim and 95 more Antonio Di Meglio Rinat Bernstein‐Molho Florentine Hilbers Katarzyna Pogoda Estela Carrasco Kevin Punie Jyoti Bajpai Michail Ignatiadis Halle C. F. Moore Kelly‐Anne Phillips Angela Toss Christine Rousset‐Jablonski Fedro A. Peccatori Tiphaine Renaud Alberta Ferrari Shani Paluch‐Shimon Robert Fruscio Wanda Cui Stephanie M. Wong Claudio Vernieri Kathryn J. Ruddy Maria Vittoria Dieci Alexios Matikas Mariya Rozenblit Cynthia Villarreal‐Garza Laura De Marchis Lucia Del Mastro Fabio Puglisi Maria Del Pilar Estevez Diz Kenny A. Rodriguez‐Wallberg Bela Mriňáková Sarah Meister Luca Livraghi Florian Clatot Rinat Yerushalmi Carmine De Angelis Rodrigo Sánchez-Bayona Icro Meattini Natalia Cichowska-Cwalińska Martine Berlière Mahmoud Salama Ugo De Giorgi Amir Sonnenblick Camila Chiodi Young‐Jin Lee Camille Maria Hatem A. Azim Luca Boni Ann H. Partridge Evandro de Azambuja Chiara Molinelli Marianne Paesmans Lieveke Ameye Frédéric Amant Hilde Brems Sileny Han Sigrid Hatse Ines Nevelsteen Patrick Neven Ann Smeets Chantal Van Rompuy Hans Wildiers François Duhoux Federica Giugliano Carmen Criscitiello Roberto Borea Luca Arecco Alessandra Chirco Federica Bini Marta Venturelli Laura Cortesi Riccardo Ponzone Nicoletta Tomasi Cont Judith Balmañà Rossella Graffeo Helena Luna Pais Alejandro Mohar Tamara Palacios Lucia Da Ros Gianmaria Miolo Mattia Garutti Brenno Pastò Simon Spazzapan Alessandra Viel José Alejandro Pérez Fidalgo Renata Colombo Bonadio Tamar Peretz‐Yablonski Chiara Annunziata Pasqualina Anghelone Angelica Della Valle Maria Campanella Valentina Guarneri Raphaëlle Bas Pierre-Étienne Heudel Olivier Trédan Solenne de Talouet

Importance Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy survivors included limited data BRCA carriers. Objective To investigate cumulative incidence disease-free survival young are Design, Setting, Participants International, multicenter, hospital-based, retrospective cohort study conducted at 78 participating centers worldwide. The...

10.1001/jama.2023.25463 article EN JAMA 2023-12-07

PURPOSE To investigate the clinical behavior of breast cancer in young BRCA carriers according to specific gene ( BRCA1 v BRCA2 ) and association timing genetic testing (before at diagnosis) with prognosis. METHODS This was an international, multicenter, hospital-based, retrospective cohort study that included 4,752 patients harboring germline pathogenic/likely pathogenic variants (PVs) or , who were diagnosed stage I-III invasive 40 years younger between January 2000 December 2020 78...

10.1200/jco-24-01334 article EN Journal of Clinical Oncology 2025-02-24

We investigated the safety and performance of Da Vinci SP single-port robot (SP robot) in nipple-sparing mastectomy (NSM) with immediate reconstruction. Medical records 60 women aged ≥ 19 years who had undergone robot-assisted unilateral or bilateral NSM reconstruction between October 2020 August 2021 were retrospectively analyzed. Stage I (31, 47.1%) was most common pathological tumor-node-metastasis stage, followed by stages II (22, 33.3%), 0 (7, 10.6%), III (4, 6.0%). The median total...

10.1038/s41598-024-84807-0 article EN cc-by-nc-nd Scientific Reports 2025-01-02

This study analyzed the pathological complete response (pCR) rates, long-term outcomes, and biological features of human epidermal growth factor receptor 2 (HER2)-zero, HER2-low, HER2-positive breast cancer patients undergoing neoadjuvant treatment. single-center included 1,667 who underwent chemotherapy from 2008 to 2014. Patients were categorized by HER2 status, their clinicopathological characteristics, responses, recurrence-free survival (RFS) rates analyzed. with HER2-low tumors more...

10.4048/jbc.2024.0268 article EN cc-by-nc Journal of Breast Cancer 2025-01-01

This study aimed to evaluate the clinical status of radiation therapy (RT), including RT utilization (RTU) rate and infrastructure in Korea 2020 2021. Patient data for individuals undergoing 2021 were sourced from Health Insurance Review Assessment Service. Through these data, we assessed following aspects: total number patients who received 2021, RTU with cancer, by cancer diagnosis, treated age, region, hypofractionated breast specific modality. In 90,351 97,840 patients, respectively,...

10.21873/anticanres.17556 article EN Anticancer Research 2025-03-28

The Avoid Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy (ASLAN) trial aims to demonstrate the oncologic safety of omitting axillary surgery in patients with excellent response after neoadjuvant chemotherapy (NACT) for early human epidermal growth factor 2 (HER2)-positive (+)/triple-negative breast cancer (TNBC) who have undergone breast-conserving (BCS) and adjuvant radiotherapy. ASLAN will provide crucial information that could change procedure highly selected undergoing NACT.

10.4048/jbc.2023.0264 article EN cc-by-nc Journal of Breast Cancer 2024-01-01

In this study, the authors compared conventional and robot-assisted mastectomy breast reconstruction. To authors' knowledge, study is first to report results of reconstruction provide a comparison patient-reported outcomes.

10.1097/prs.0000000000011205 article EN Plastic & Reconstructive Surgery 2023-11-20

To determine how pulmonary paragonimiasis may be confused with lung cancer, we retrospectively analysed the clinical and radiological characteristics of 47 patients (27 males, median age 55 years; interquartile range 49-61) serologically or histopathologically confirmed seen between October 2004 December 2009.Respiratory symptoms were present in 29 (62%) patients; remaining 18 (38%) asymptomatic. Chest radiography (CXR) revealed intrapulmonary parenchymal lesions (n = 35, 75%) more...

10.5588/ijtld.10.0494 article EN The International Journal of Tuberculosis and Lung Disease 2011-04-11

(Abstracted from JAMA 2024;331(1):49–59 Individuals who are diagnosed with breast cancer at a young age often carriers of pathogenic variant in the BRCA1 or BRCA2 genes, and many women this situation interested preserving future fertility, if possible. Reproductive counseling can be complex due to risk passing on variant, as well implications their own mutation impact ovarian reserve, fertility potential, other factors.

10.1097/ogx.0000000000001311 article EN Obstetrical & Gynecological Survey 2024-08-01

Nonmass lesions (NMLs) on breast ultrasound lack clear definition and encompass a broad range of benign malignant entities. Given anticipated inclusion NMLs in the BI-RADS 6th edition, thorough understanding these will be critical for optimal management.

10.2214/ajr.24.32278 article EN American Journal of Roentgenology 2024-12-18

OBJECTIVES: Clinicians might be misled in interpreting an elevated CA19-9 when differentiating pancreaticobiliary cancer from benign clinical conditions such as acute cholangitis or cholestasis, because these conditions, the concentration of may also elevated. The aims our study were to calculate new individual cutoff values for according situations using a receiver operating characteristic (ROC) curve and define strategy cancer. METHODS: One hundred sixty patients with pancreatic diseases...

10.1016/s0002-9270(99)00290-7 article EN The American Journal of Gastroenterology 1999-07-01

This study aimed to analyze the waiting time for initial treatment after breast cancer diagnosis and determine factors influencing delay in South Korea.This nationwide retrospective cohort was conducted using Health Insurance Review Assessment data. The participants were classified according regions where their biopsy performed (Seoul-Seoul, Metro-Metro, Other-Other, Metro-Seoul, Other-Seoul). Waiting analyzed regional subgroup, year of diagnosis, type treatment. Multivariable logistic...

10.4048/jbc.2023.26.e26 article EN cc-by-nc Journal of Breast Cancer 2023-01-01

Abstract Background Imaging-guided or physiology-guided percutaneous coronary intervention (PCI) improved clinical outcomes in complex artery disease. However, it is not known to what extent routine functional testing after imaging PCI affect among high-risk patients. Objectives To assess impact of test standard care alone intravascular ultrasound (IVUS) fractional flow reserve(FFR) guided PCI. Methods Of the 1706 randomized patients with anatomical features enrolled POST-PCI (Pragmatic...

10.1093/eurheartj/ehad655.1245 article EN European Heart Journal 2023-11-01

One of major threatening search and destroy MRSA is rising mupirocin resistance. In a 2,200-bed tertiary care hospital, only 38-bed neonatal intensive unit (NICU) was under active surveillance decolonization colonizers for last 10 years. Mupirocin resistances isolates from NICU clinical Staphylococcus aureus the institute were compared.

10.1186/1753-6561-5-s6-p171 article EN cc-by BMC Proceedings 2011-06-29

Abstract Background: Oncofertility counseling in BRCA carriers has unique challenges due to a possible negative impact of germline pathogenic/likely pathogenic variants (PVs) on reproductive potential and the indication undergo risk-reducing bilateral salpingo-oophorectomy. While previous studies demonstrated safety pregnancy women with prior breast cancer (BC) history, limited evidence exists specifically. We report results largest study date investigating likelihood after BC, disease...

10.1158/1538-7445.sabcs23-gs02-13 article EN Cancer Research 2024-05-02

Abstract Background Neoadjuvant chemotherapy (NACT) for breast cancer (BC) is downstaging inoperable tumors into operable and de-escalating breast/axillary surgery. According to advanced NACT, dual human epidermal growth factor-2 (HER2) blockage in HER2-positive BC, carboplatin, immunotherapy triple-negative (TNBC) revealed pathologic complete response (ypCR) rates of up 68% 80%, the indications NACT have expanded early BC expected ypCR rate has increased. Therefore, it may be reasonable...

10.1158/1538-7445.sabcs23-po4-19-10 article EN Cancer Research 2024-05-02

Abstract Background and Aims Cutaneous manifestations are frequently found in end-stage kidney disease (ESKD) disturbing quality of life patients under maintenance hemodialysis. Even dialysis visit the hospital, they do not receive active dermatologic care. The aim this study is to assess cutaneous hemodialysis investigate changes before after treatment by dermatologists. Method A 12-weeks, prospective was conducted with two centers Patients one center received intervention another...

10.1093/ndt/gfae069.1628 article EN other-oa Nephrology Dialysis Transplantation 2024-05-01

546 Background: Invasive Lobular Carcinoma (ILC), a unique breast cancer subtype, exhibits distinct clinical and pathological features. Multigene assays, notably the Oncotype DX (ODX) test, provide personalized prognostic insights in cancer. However, research gap exists for clinical-pathological characteristics affecting multigene assay risk scores ILC. This study aims to address this gap, investigating factors specific ILC, from those invasive ductal carcinoma (IDC), contributing refined...

10.1200/jco.2024.42.16_suppl.546 article EN Journal of Clinical Oncology 2024-05-29
Coming Soon ...